Bixiye
QP6-20 Separate Remits Will be Sent for Processed Legacy Platform Runout Claims
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2591 - 2600 ee natiijooyinka 3289
Bixiye
QP7-20 Pharmacy Benefit Exclusion for Vyondys 53 (golodirsen)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP1-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Palforzia and Viaskin Peanut (Peanut Allery Oral Immunotherapy)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP4-20 Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Behavioral Health Fax Back Notification Update
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP5-20 Pharmacy Benefit Exclusions
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP3-20 Addition of Mille Lacs Corporate Ventures to the American Indian Tribal Fee Schedule for Eligible Facility and Professional Services Provided to Purchased/Referred Care (PRC) – Eligible American Indians
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP2-20 MHCP Medical Dental Claim Denials
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP8-20 Medical Drug Update for New to Market Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
P1-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective March 2, 2020
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020
Bixiye
P8-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020